Analysts forecast LS tech and business trend of 2022

AI drug discovery platform raises Series B funding

Industry analyst discusses biotech firm lifecycle

The Source Code of Life

European Biotech Investors Cap Off Record Year in Fundraising

Venture capitalists raise more than $100bn to target life sciences

Global data and analysis on dealmaking, funding, and exits in private-market companies

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

The Bright New Age of Venture Capital

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”